Orit Markowitz is a Nonmelanoma Skin Cancer Studies physician affiliated with SUNY Downstate Health Sciences University. OpenAlex indexes 80 publications with 838 citations (h-index 15); ClinicalTrials.gov lists 4 registered studies with this person as an investigator.
Data verified 28 Oct 2026
Overview
Updated 28 Oct 2026
Orit Markowitz is affiliated with SUNY Downstate Health Sciences University. The public record shows 80 publications with 838 citations (h-index 15), centered on Nonmelanoma Skin Cancer Studies, Cutaneous Melanoma Detection and Management, Optical Coherence Tomography Applications. It also documents an investigator role on 4 registered clinical trials, industry payments reported by 30 companies.
- Most recent indexed publication: 2026 · Lasers in surgery and medicine
- Top research focus: Nonmelanoma Skin Cancer Studies
- 4 registered trials on ClinicalTrials.gov
- Open Payments reporting from 30 companies
Generated from the cited public record · current as of 28 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 2 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 24.
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 28 Oct 2026
Listed as an investigator on 4 registered studies on ClinicalTrials.gov. The most recent:
- Dupilmuab for Atopic Dermatitis Monitored With Noninvasive Imaging.
Sponsor: OptiSkin Medical
- Etanercept Therapy for Nails Psoriasis Monitoring With Noninvasive Imaging
Sponsor: OptiSkin Medical
Industry payments
Updated 28 Oct 2026
30 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Galderma Laboratories, L.P.Program year202512 payments$17,346openpaymentsdata.cms.gov ↗
- SUN PHARMACEUTICAL INDUSTRIES INC.Program year20255 payments$10,097openpaymentsdata.cms.gov ↗
- GENZYME CORPORATIONProgram year20253 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
26.5%Corticosteroid13.3%Mometasone Furoate100%Part D≥101 patientsRNA Synthetase Inhibitor Antibacterial13.2%Mupirocin100%Part D≥99 patientsAnti-infectives
22%Azole Antifungal12.5%Ketoconazole100%Part D≥67 patientsHerpesvirus Nucleoside Analog DNA Polymerase Inhibitor4.6%Valacyclovir100%Part D≥27 patients+ 2 more classes in this area
Dermatology
21%Corticosteroid18%Triamcinolone Acetonide53%Triamcinolone acetonide41%Fluocinolone Acetonide7%Part D + Part B≥76 patientsVitamin D Analog1.7%Calcipotriene100%Part D≥16 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Publications
Updated 28 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Combining Nd:YAG laser with optical coherence tomography for nonsurgical treatment of basal cell carcinoma.
Lasers in surgery and medicine
Case Report2022
Most-cited works
by citation count (OpenAlex)- 01Introduction to reflectance confocal microscopy and its use in clinical practiceEditorial132 citations2018
- 02Optical Coherence Tomography in the Diagnosis of Skin CancerArticle87 citations2017
- 03
- 04
- 05
Network
Updated 28 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Similar KOLs
Other experts from the same institution or the same specialty.
Michael Weber, MD
SUNY Downstate Health Sciences University
Jared Jagdeo, MD
SUNY Downstate Health Sciences University
John Danias, MD, PhD
SUNY Downstate Health Sciences University
Ellen Ginzler, MD
SUNY Downstate Health Sciences University
Jedd Wolchok, MD
Weill Cornell Medicine
Frank Hodi, MD
Dana-Farber Cancer Institute
Keith Flaherty, MD
Massachusetts General Hospital
Omid Hamid, MD
The Angeles Clinic and Research Institute